Fusion Pharmaceuticals Inc (FUSN)
21.42
-0.02
(-0.12%)
USD |
NASDAQ |
May 06, 16:00
21.42
0.00 (0.00%)
After-Hours: 18:43
Fusion Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -860.0% |
| June 30, 2023 | -74.04K% |
| March 31, 2023 | -86.75K% |
| December 31, 2022 | -17.58K% |
| September 30, 2022 | -14.47K% |
| Date | Value |
|---|---|
| June 30, 2022 | -3.35K% |
| March 31, 2022 | -3.40K% |
| December 31, 2021 | -2.90K% |
| September 30, 2021 | -5.98K% |
| June 30, 2021 | -5.15K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-86.75K%
Minimum
Mar 2023
-860.0%
Maximum
Sep 2023
-21.45K%
Average
-5.57K%
Median
Profit Margin (Quarterly) Benchmarks
| AstraZeneca PLC | 17.19% |
| Landos Biopharma Inc | -- |
| Perspective Therapeutics Inc | -- |
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | -59.60% |